Interpace Biosciences (IDXG) Reports Q4 EPS of $0.82
Tweet
Share
E-mailGet Alerts IDXG Hot Sheet
Join SI Premium – FREE
Interpace Biosciences (OTC: IDXG) reported Q4 EPS of $0.82.Revenue for the quarter came in at $9.22 million.
For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grok Bot launches in early beta for select subscribers
- On Holding AG (ONON) Removed from Raymond James Analyst Current Favorites List
- Barclays sees improved biofuel market fundamentals
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
